Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study - Poll - MDSpire

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

  • By

  • Jingjing Lu

  • Xuelian Song

  • Chen Zhang

  • Yi Zhu

  • Huarui Yang

  • Yi Li

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

  • by Jingjing Lu, Xuelian Song, Chen Zhang, Yi Zhu, Huarui Yang, Yi Li

  • June 8, 2026

Related Content

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review

Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies

Primary diffuse large b-cell lymphoma of the lip: a case report and literature review